CPHI vs USB
China Pharma Holdings Inc (CPHI) versus U.S. Bancorp (USB) — a side-by-side from cached financials, not a winner call.
China Pharma Holdings Inc (CPHI) is a drug manufacturers - specialty & generic company listed on US.
U.S. Bancorp (USB) is a banks - regional company listed on US.
Latest reported CPHI revenue for 2024-12-31 was $4.5M. Net income was -$4.7M. Revenue was down 35.4% from 2023-12-31 to 2024-12-31. CPHI currently screens at market cap $29.0M.
Latest reported USB revenue for 2025-12-31 was $28.66B. Net income was $7.57B. Revenue was up 4.4% from 2024-12-31 to 2025-12-31. USB currently screens at market cap $74.68B and trailing P/E 11.9.
CPHI currently screens at market cap $29.0M. USB currently screens at market cap $74.68B and trailing P/E 11.9.
Not investment advice. Open the CPHI and USB stock pages for the full models.
Not investment advice.